Skip to main content

ORIGINAL RESEARCH article

Front. Neurol., 26 May 2023
Sec. Epilepsy
This article is part of the Research Topic Neuromodulation for Pharmacoresistant Epilepsy: from Bench to Bed View all 11 articles

Effects of altered excitation–inhibition imbalance by repetitive transcranial magnetic stimulation for self-limited epilepsy with centrotemporal spikes

\r\nYujiao Yang&#x;Yujiao Yang1Yixian Han&#x;Yixian Han1Jing WangJing Wang1Yongkang ZhouYongkang Zhou1Dong ChenDong Chen2Mengyang Wang
Mengyang Wang1*Tianfu Li,,
Tianfu Li1,3,4*
  • 1Department of Neurology, Sanbo Brain Hospital, Capital Medical University, Beijing, China
  • 2CAS Key Laboratory of Mental Health, Institute of Psychology, Beijing, China
  • 3Beijing Key Laboratory of Epilepsy, Sanbo Brain Hospital, Capital Medical University, Beijing, China
  • 4Beijing Institute for Brain Disorders, Capital Medical University, Beijing, China

Objectives: Patients with self-limited epilepsy with centrotemporal spikes (SeLECTS) with electrical status epilepticus in sleep (ESES) have generalized cognitive impairment, yet treatment options are limited. Our study aimed to examine the therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) on SeLECTS with ESES. In addition, we applied electroencephalography (EEG) aperiodic components (offset and slope) to investigate the improvement of rTMS on the excitation–inhibition imbalance (E-I imbalance) in the brain of this group of children.

Methods: Eight SeLECTS patients with ESES were included in this study. Low-frequency rTMS (≤1 Hz) was applied for 10 weekdays in each patient. To assess the clinical efficacy and changes in E-I imbalance, EEG recordings were performed both before and after rTMS. Seizure-reduction rate and spike-wave index (SWI) were measured to investigate the clinical effects of rTMS. The aperiodic offset and slope were calculated to explore the effect of rTMS on E-I imbalance.

Results: Five of the eight patients (62.5%) were seizure-free within 3 months after stimulation, with treatment effects decreasing with longer follow-ups. The SWI decreased significantly at 3 and 6 months after rTMS compared with the baseline (P = 0.0157 and P = 0.0060, respectively). The offset and slope were compared before rTMS and within 3 months after stimulation. The results showed a significant reduction in the offset after stimulation (P < 0.0001). There was a remarkable increase in slope after the stimulation (P < 0.0001).

Conclusion: Patients achieved favorable outcomes in the first 3 months after rTMS. The ameliorative effect of rTMS on SWI may last up to 6 months. Low-frequency rTMS could reduce firing rates in neuronal populations throughout the brain, which was most pronounced at the site of stimulation. A significant reduction in the slope after rTMS treatment suggested an improvement in the E-I imbalance in the SeLECTS.

1. Introduction

Self-limited epilepsy with centrotemporal spikes (SeLECTS) is the most common focal syndrome in childhood epilepsy (1). Most children with SeLECTS have a good prognosis, but a small percentage may evolve into epileptic encephalopathy with spike-and-wave activation in sleep (EE-SWAS). The EEG pattern associated with EE-SWAS is known as electrical status epilepticus in sleep (ESES) (2). The nearly constant epileptiform activity of slow-wave sleep is usually accompanied by significant regression in cognitive or behavioral function. All cognitive domains may be affected, including language and communication, temporospatial orientation, attention, and social interaction. However, existing treatments remain very limited in their ability to effectively reduce functional impairment in SeLECTS patients with ESES.

Repetitive transcranial magnetic stimulation (rTMS), as a focal, non-invasive technique, has therapeutic potential in the field of epilepsy (3). Low-frequency rTMS (≤1 Hz) inhibits cortical excitability, increases cortical silent period duration, and reduces motor-evoked potential amplitudes (4). The rationale for using low-frequency rTMS to suppress seizures is related to the fact that it is promising to interrupt synaptic potential and focal cortical excitability. Real-world evidence suggests that low-frequency rTMS using a figure-8-coil may be an effective therapy for drug-resistant epilepsy in pediatric patients, resulting in a 30% reduction in seizure frequency (5). Ren et al. found that rTMS acted as a novel approach to behavioral problems that are highly prevalent in patients with SeLECTS (6). Although a Cochrane review found rTMS to be safe and effective in reducing epileptiform discharges, the evidence for the efficacy of rTMS for seizure reduction is still lacking (7).

The imbalance between excitatory and inhibitory properties (E-I imbalance) in SeLECTS has been identified as contributing to seizures and cognitive impairment (8). The inhibitory network involves both sensorimotor and subcortical networks, which manifest as a dissociation of the corresponding functions. However, the effect of rTMS on improving the E-I imbalance in SeLECTS patients is unclear. We hypothesized that rTMS would reduce seizure frequency and E-I imbalance in SeLECTS. To address our hypothesis, two requirements need to be met: (1) whether seizure frequency and epileptiform discharges are reduced after rTMS and (2) whether the E-I imbalance can be improved by rTMS.

2. Methods

2.1. Patient selection

This study was a retrospective analysis of patients with SeLECTS who visited the Sanbo Brain Hospital from January 2015 to December 2020. The inclusion criteria were as follows: (1) age of onset between 3 and 15 years; (2) appropriate seizure semiology which suggested focal onset (9); (3) centrotemporal spikes on EEG and unilateral spike-wave index (SWI) >80% or bilateral SWI >50%; (4) the neuropsychology test showed that intelligence quotient (IQ) was lower than normal intellectual development; (5) TMS treatment; and (6) at least one EEG exanimation after TMS. We excluded children with a history of prematurity (<35 weeks), abnormal magnetic resonance imaging (MRI) of the brain, other epilepsy syndromes, neurosurgery, and severe brain injury. This study was approved by the Ethics Committee of Sanbo Brain Hospital, Capital Medical University.

2.2. EEG recordings

The EEGs were recorded based on the standard international 10–20 system, with 19 scalp electrodes. The recording system used was Nicolet. EEG recordings during sleep and awake were obtained. The EEG signal was recorded at 512 Hz or 1,024 Hz. Impedance levels for each electrode were at or below 50 kΩ during data collection. EEG was referenced online to the central midline electrode site (Cz). The SWI was reviewed by an independent epileptologist blinded to the clinical data.

2.3. Neuropsychological evaluation

All patients underwent evaluation for intellectual and behavioral impairment using standard assessment procedures. The Wechsler Intelligence Scale for Children, fourth edition (WISC-IV), was used to measure the intelligence level of children at the baseline.

2.4. rTMS procedure

In our study, rTMS was performed on all patients using Magstim (Company Ltd.). The figure-8-coil plane targeting the stimulation site was tangential and was kept parallel to the scalp. The stimulus parameters were as follows: frequency ≤1 Hz; intensity, reference resting motor threshold; and the number of stimuli, 500/1,000/1,500 per site, depending on the frequency. The treatment lasted for 10 weekdays. The stimulation site was the central region (C5 or C6). The determination of the stimulation site was based on a combination of seizure symptoms, EEG, and abnormalities of positron emission tomography (PET) metabolism in the brain.

2.5. EEG data analysis

The EEGLAB toolbox in MATLAB was used to analyze the raw EEG data. The EEG was re-referenced to the average of all electrodes. We applied a 1 Hz bandpass filter and 80 Hz cutoff to the data. Independent components analysis was used to correct eye blink artifacts for correction.

The power spectral density (PSD) was calculated at 0.5 Hz increments from 1 Hz to 40 Hz using Welch's method (10 s time window, 0.5 s window length, 50% overlap). The “Fitting Oscillations and One-Over-f” (FOOOF) toolbox was used to calculate the aperiodic component (offset and slope). The PSD slope is equivalent to the negative exponent when measured in log–log space due to aperiodic activity having a 1/f-like distribution with exponentially decreasing power across increasing frequencies (10). The E-I ratio could be estimated from the PSD slope. The steeper the slope is, the lower the E-I ratio (11). A more negative slope indicates that relatively more inhibition occurs in the underlying neuronal populations (12). The power spectrum, P, was modeled using three parameters:

P=L+n=0NGn ,    (1)

where L is the aperiodic “background” signal, with N total peaks extracted from the power spectrum and Gaussians (Gn) fitted to each peak. The peaks were iteratively fitted by Gaussians:

Gn=a*exp(-(F-c)22w2),    (2)

with an amplitude, center frequency, c, the bandwidth, w, of the Gaussian G, and the input frequencies, F. The aperiodic signal L was modeled by

L=b-log(k+Fχ),    (3)

where b is the broadband offset, x is the slope, and k is the “knee” parameter, which was set to 0. The FOOOF model was fitted for the frequency range of 1–40 Hz.

2.6. Follow-up program

Each patient was assessed for seizure frequency, SWI, WISC-IV, offset, and slope before treatment and observed after 10 working days of low-frequency stimulation. Seizure frequency, SWI, offset, and slope were assessed at 3 months post-treatment. Seizure frequency and SWI were measured at 6 months and 12 months post-treatment.

2.7. Statistical analysis

To test whether there were significant differences between baseline measurements before rTMS and follow-up measurements after rTMS, the pairwise comparison method was applied. First, a normality test was performed. If all groups met the normality and the variation between the two groups was homogeneous, a paired t-test was used. A non-parametric Wilcoxon matched-pairs signed rank test was considered if all groups did not meet the normality test. P-values < 0.05 were considered to be statistically significant. P-values were corrected with the original false discovery rate (FDR) method of Benjamini and Hochberg.

3. Results

3.1. Clinical information

Eight patients with SeLECTS were enrolled, 4 female and 4 male patients. Follow-up visits were scheduled at 3, 6, and 12 months after rTMS. The follow-up schedule is shown in Supplementary Figure S1. The mean age at the onset of epilepsy was 4.5 years (range 3–7), and the mean age at the first visit was 5.9 years (range 4–7). Two children (patients 2 and 4) had a previous history of febrile convulsions. The mean SWI before rTMS was 86.58% (range 74.33–97.67%). MRI was normal in all of them. The mean IQ was 76.5 (range 67–84). Detailed information is listed in Table 1 and Supplementary Tables S1, S2.

TABLE 1
www.frontiersin.org

Table 1. Patients' clinical information.

3.2. Treatment effects after rTMS

3.2.1. Seizure frequency reduced by rTMS

Five of the eight patients (62.5%) were seizure-free within 3 months after stimulation, and the other three had < 50% reduction in seizure frequency. Within 6 months after rTMS, four patients had a reduction in seizure frequency of more than 50%, two patients had a reduction of about 30%, one patient returned to baseline and one patient had an increase in seizure frequency. Within 12 months after rTMS, three patients had achieved complete seizure-free status, three had seizure reduction by more than 50%, and two had a decrease by approximately 30% (Figure 1).

FIGURE 1
www.frontiersin.org

Figure 1. Seizure frequency reduced by rTMS. Five of the eight patients (62.5%) were seizure-free within 3 months after stimulation, and the other three had less than a 50% reduction in seizure frequency (red). Within 6 months after rTMS, seizure frequency was reduced by more than 50% in four patients, and approximately 30% in two patients, returned to the baseline level in one patient, and increased in one patient (blue). Within 12 months after rTMS, three patients had achieved complete seizure-free, three had seizure reduction by more than 50%, and two decreased by approximately 30% (green).

3.2.2. SWI before and after rTMS

The SWI at 3 months was reduced significantly by rTMS (P = 0.0157) (Figure 2A). The SWI at 6 months after rTMS was remarkedly lower than that before rTMS (P = 0.0060) (Figure 2B). There was no significant difference in SWI at 12 months after rTMS and before rTMS (Figure 2C).

FIGURE 2
www.frontiersin.org

Figure 2. SWI before and after rTMS. (A) SWI before rTMS and 3 months after rTMS. (B) SWI before rTMS and 6 months after rTMS. (C) SWI before rTMS and 12 months after rTMS.

3.3. Evolution of excitability after rTMS

3.3.1. Aperiodic offset before and after rTMS

We evaluated whether rTMS could alter the PSD offset. The offset of all scalp electrodes before rTMS was compared with that at 3 months after rTMS. A significant decrease was observed after stimulation (P < 0.0001) (Figure 3A). We further analyzed whether differences existed in different brain regions. It was found that the most significant changes were in brain areas around the stimulation sites (Figure 3B).

FIGURE 3
www.frontiersin.org

Figure 3. Aperiodic offset before and after rTMS. (A) PSD offset before rTMS and 3 months after rTMS. There was a significant reduction in PSD offset after stimulation (P < 0.0001). (B) T-value distributed in different brain regions.

3.3.2. Aperiodic slope before and after rTMS

We assessed whether rTMS could change the E-I imbalance. The PSD slope of all scalp electrodes before rTMS and 3 months after rTMS was compared. It was found that there was a significant increase in PSD slope after stimulation (P < 0.0001) (Figure 4A). To analyze the differences in different brain regions, we observed that the most prominent alteration was in the scalp electrodes at the stimulation site (Figure 4B).

FIGURE 4
www.frontiersin.org

Figure 4. Aperiodic slope before and after rTMS. (A) PSD slope before rTMS and 3 months after rTMS. There was a significant reduction in PSD slope after stimulation (P < 0.0001). (B) T-value distributed in different brain regions.

4. Discussion

The present study aimed to evaluate whether rTMS could clinically benefit SeLECTS patients and modify E-I imbalance. To achieve this goal, our research was divided into two parts. In the first part, we assessed the clinical efficacy of TMS. Seizure-reduction rate and SWI were compared before and after rTMS. The results found that rTMS reduced seizure frequency for at least 3 months. The SWI was decreased by rTMS at 3 and 6 months. In the second part, we applied a special parametric approach to analyze the aperiodic offset and slope. We observed a significant reduction in aperiodic offset after rTMS, reflecting a decline in the spiking rate of cortical neurons. Among all channels, the most dramatic changes occurred around the rTMS stimulation site. The aperiodic slope after rTMS was increased, suggesting that the E-I imbalance was altered by stimulation. Similarly, the most obvious change was around the rTMS site.

4.1. Excitation–inhibition imbalance in SeLECTS

SeLECTS is characterized cardinally by sensory-motor seizures, oro-pharyngo-laryngeal symptoms, speech arrest, and hypersalivation, which are associated with abnormal discharges in the Rolandic areas (13, 14). Children with SeLECTS have a less stable network of areas involved in sensorimotor function (15). The function of bilateral sensorimotor areas is disorganized, as evidenced by a significant delay in motor control and impaired language function (16). The diseased neuronal networks are less efficient and may cause language impairments (17). The deficits in the language domain may be a downstream effect of altered motor cortex function possibly due to diffusion of activity to areas involved in language processing and/or as a result of motor execution difficulties, such as tongue immobility (1719).

The concept of epilepsy as a spectrum disorder is increasingly acknowledged and patients frequently exhibit comorbid cognitive and behavioral impairments (20). Patients with SeLECTS with ESES exhibit an onset of symptoms during a critical period of brain development, which is the most vulnerable time for cognitive function. In addition to seizures, this group of patients is often associated with reduced cognitive function and impaired executive function (21, 22). Of the numerous factors that influence executive dysfunction in patients with SeLECTS, the most significant correlations are observed with the age of onset, frequency of intermittent discharges, and alterations in brain networks (22). During early childhood, the brain exhibits high levels of neuroplasticity and relatively low functional specificity of neural networks. Seizures at this stage can significantly impact children's executive and memory functions (23). The effect on the child's attentional network varies with the frequency of intermittent discharges and is more pronounced if the onset occurs at a younger age of onset (24). Functional and structural brain connections may be altered in children with SeLECTS, resulting in cognitive dysfunction, particularly executive function abnormalities (25, 26). Relevant evidence derived from resting-state functional MRI also suggests that reduced functional connectivity in Rolandic areas may exert an impact on the wider brain network (27).

Numerous studies have shown that the balance between excitatory and inhibitory electrical activity of neurons in the brain is dynamically regulated under normal conditions. However, in patients with epilepsy, the balance is disturbed, resulting in a relative increase in excitatory neuronal activity, either directly or indirectly (28, 29). Studies based on support vector machine models of Granger causal density have revealed abnormalities in connectivity both between and within different networks in patients with SeLECTS (30). Frequent intermittent epileptic discharges can lead to irreversible reconfiguration of neural networks, resulting in an imbalance between excitation and inhibition (31). The excitation–inhibition imbalance in brain networks further leads to cognitive dysfunction and seizures (20, 32), making it a potential biological marker for SeLECTS (8).

4.2. RTMS improves E-I imbalance in SeLECTS

TMS exhibits diagnostic and therapeutic potential in the field of epilepsy. As an assessment tool, TMS can be combined with EMG to provide biological markers for indicators of cortical excitation and inhibition associated with epilepsy and antiepileptic drugs (33). Therapeutically, low-frequency rTMS (≤1 Hz) can effectively prolong postsynaptic inhibition and reduce brain excitability. During both interictal and ictal periods, TMS can be utilized to varying degrees to reduce the frequency or severity of seizures or even terminate them (3). However, few studies are using EEG signals to evaluate the improvement of the cortical excitation–inhibition ratio by TMS. The present study may serve as a supplementary and guiding reference for rTMS treatment in epilepsy.

Studies of intracranial local field potential have shown that broadband power offsets are positively correlated with the firing rate of neuronal populations (34). Similar results have been observed in macaque studies correlating neuronal action potentials with instantaneous changes in broadband local field potentials (35). Other studies have shown that whole-brain aperiodic offset is inversely correlated with age, and it is speculated that this phenomenon may be due to a decrease in the firing rate of cortical neurons as the brain matures with age (36). In the present study, the PSD offset decreased after rTMS, reflecting the reduction in cortical neuronal firing and the suppression of action potentials in neuronal populations. Although this was observed on all electrodes, it tended to be more pronounced near the stimulated area. However, the explanatory relationship between the observed phenomenon and the mechanism of TMS remains speculative, and a more precise causal relationship requires further experimental confirmation.

The excitation–inhibition imbalance may lead to hyper-synchronization of the electrical activity of neurons in epileptic networks (29). The slope of the aperiodic PSD signal reflects the balance between excitation and inhibition (11). With an increase in age, the aperiodic slope tends to decrease. In studies of visual working memory tasks, older adults show a relatively flat slope, whereas younger adults show a steeper slope (37). Relevant evidence suggests that an increase in excitation–inhibition ratio may result in a flatter PSD slope, indicating a reduced synchronization of neuronal firing (38). A positive correlation was found between the excitation–inhibition ratio and the PSD slope, while a stronger correlation was found between the synaptic density of inhibitory neurons and the PSD slope. In the present study, the increase in PSD slope after rTMS treatment might be due to the increased application of stimulation effects to inhibitory neurons, resulting in improved function of the SeLECTS inhibitory loop and, thus, a reduction in the excitation–inhibition imbalance. However, this is conjecture, and further studies are needed to elucidate the cytological and molecular mechanisms involved.

5. Limitations

There are some limitations in the present study. The sample size was 8, and there was some individual variation that may have influenced the results. The number of EEG electrodes was 19, which may have led to a lack of accuracy in the spatial sampling of electrical brain activity. We did not assess the Wechsler Intelligence Scale for post-treatment assessment and thus cannot yet determine whether rTMS can improve cognitive performance. The most important and difficult point is that since the study is limited to the processing of EEG signals, the results are presented as phenomena and we are not yet able to explain the mechanism of action of rTMS. We have established a more standardized process to compensate for the above limitations to allow for more discoveries in the future.

6. Conclusion

Favorable clinical outcomes are observed in patients within the initial 3-month period following rTMS treatment. After treatment, the patient's SWI is significantly reduced, and the effect lasts for up to 6 months. Low-frequency rTMS induces a reduction in neuronal firing, particularly at the site of stimulation. The E-I imbalance can be improved in SeLECTS after rTMS intervention.

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving human participants were reviewed and approved by Ethics Committee of Sanbo Brain Hospital, Capital Medical University. Written informed consent to participate in this study was provided by the participants' legal guardian/next of kin.

Author contributions

TL and MW contributed to the conception and design of the study. YY and YH contributed to the writing and preparation of the figures. YH and YZ contributed to analyzing the data. JW contributed to reviewing the EEG data. DC contributed to interpreting the results. All authors contributed to the acquisition and analysis of data, reviewed, and revised the manuscript for intellectual content.

Funding

This study was supported by the Sanbo Brain Hospital, Capital Medical University (2021ZZLX01), China Association Against Epilepsy Research Fund (CU-A-2021-10), the STI2030-Major Projects (2022ZD0205000), and Hygiene and Health Development Scientific Research Fostering Plan of Haidian District Beijing (HP2021-03-50801).

Acknowledgments

We thank the patients who participated in this research.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fneur.2023.1164082/full#supplementary-material

References

1. Specchio N, Wirrell EC, Scheffer IE, Nabbout R, Riney K, Samia P, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia. (2022) 63:1398–442. doi: 10.1111/epi.17241

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Fernández IS, Chapman KE, Peters JM, Kothare SV, Jr DRN, Jensen FE, et al. The tower of Babel: survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America. Epilepsia. (2013) 54:741–50. doi: 10.1111/epi.12039

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Tsuboyama M, Kaye HL, Rotenberg A. Review of Transcranial Magnetic Stimulation in Epilepsy. Clin Ther. (2020) 42:1155–68. doi: 10.1016/j.clinthera.2020.05.016

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Iglesias AH. Transcranial Magnetic Stimulation as Treatment in Multiple Neurologic Conditions. Curr Neurol Neurosci Rep. (2020) 20:1. doi: 10.1007/s11910-020-1021-0

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Cooper YA, Pianka ST, Alotaibi NM, Babayan D, Salavati B, Weil AG, et al. Repetitive transcranial magnetic stimulation for the treatment of drug-resistant epilepsy: A systematic review and individual participant data meta-analysis of real-world evidence. Epilepsia Open. (2018) 3:55–65. doi: 10.1002/epi4.12092

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Jin G, Chen J, Du J, He L, Qi L, Wu D, et al. Repetitive transcranial magnetic stimulation to treat benign epilepsy with centrotemporal spikes. Brain Stimul. (2022) 15:601–4. doi: 10.1016/j.brs.2022.04.003

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Walton D, Spencer DC, Nevitt SJ, Michael BD. Transcranial magnetic stimulation for the treatment of epilepsy. Cochrane Database Syst Rev. (2021) 4:CD011025. doi: 10.1002/14651858.CD011025.pub3

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Dai XJ, Liu H, Yang Y, Wang Y, Wan F. Brain network excitatory/inhibitory imbalance is a biomarker for drug-naive Rolandic epilepsy: A radiomics strategy. Epilepsia. (2021) 62:2426–38. doi: 10.1111/epi.17011

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, et al. Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology. Epilepsia. (2017) 58:522–30. doi: 10.1111/epi.13670

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Miller KJ, Sorensen LB, Ojemann JG, den Nijs M. Power-law scaling in the brain surface electric potential. PLoS Comput Biol. (2009) 5:e1000609. doi: 10.1371/journal.pcbi.1000609

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Gao R, Peterson EJ, Voytek B. Inferring synaptic excitation/inhibition balance from field potentials. Neuroimage. (2017) 158:70–8. doi: 10.1016/j.neuroimage.2017.06.078

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Donoghue T, Haller M, Peterson EJ, Varma P, Sebastian P, Gao R, et al. Parameterizing neural power spectra into periodic and aperiodic components. Nat Neurosci. (2020) 23:1655–65. doi: 10.1038/s41593-020-00744-x

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Eickhoff SB, Grefkes C, Fink GR, Zilles K. Functional lateralization of face, hand, and trunk representation in anatomically defined human somatosensory areas. Cereb Cortex. (2008) 18:2820–30. doi: 10.1093/cercor/bhn039

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Panayiotopoulos CP, Michael M, Sanders S, Valeta T, Koutroumanidis M. Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. Brain. (2008) 131:2264–86. doi: 10.1093/brain/awn162

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Koelewijn L, Hamandi K, Brindley LM, Brookes MJ, Routley BC, Muthukumaraswamy SD, et al. Resting-state oscillatory dynamics in sensorimotor cortex in benign epilepsy with centro-temporal spikes and typical brain development. Hum Brain Mapp. (2015) 36:3935–49. doi: 10.1002/hbm.22888

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Overvliet GM, Aldenkamp AP, Klinkenberg S, Nicolai J, Vles JSH, Besseling RMH, et al. Correlation between language impairment and problems in motor development in children with rolandic epilepsy. Epilepsy Behav. (2011) 22:527–31. doi: 10.1016/j.yebeh.2011.08.012

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Overvliet GM, Besseling RMH, Vles JSH, Hofman PAM, Backes WH, van Hall MHJA, et al. Nocturnal epileptiform EEG discharges, nocturnal epileptic seizures, and language impairments in children: review of the literature. Epilepsy Behav. (2010) 19:550–8. doi: 10.1016/j.yebeh.2010.09.015

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Lundberg S, Frylmark A, Eeg-Olofsson O. Children with rolandic epilepsy have abnormalities of oromotor and dichotic listening performance. Dev Med Child Neurol. (2005) 47:603–8. doi: 10.1111/j.1469-8749.2005.tb01211.x

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Overvliet GM, Aldenkamp AP, Klinkenberg S, Vles JS, Hendriksen J. Impaired language performance as a precursor or consequence of Rolandic epilepsy? J Neurol Sci. (2011) 304:71–4. doi: 10.1016/j.jns.2011.02.009

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Jensen FE. Epilepsy as a spectrum disorder: Implications from novel clinical and basic neuroscience. Epilepsia. (2011) 52 Suppl 1:1–6. doi: 10.1111/j.1528-1167.2010.02904.x

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Nabbout R, Dulac O. Epileptic encephalopathies: a brief overview. J Clin Neurophysiol. (2003) 20:393–7. doi: 10.1097/00004691-200311000-00002

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Zanaboni MP, Varesio C, Pasca L, Foti A, Totaro M, Celario M, et al. Systematic review of executive functions in children with self-limited epilepsy with centrotemporal spikes. Epilepsy Behav. (2021) 123:108254. doi: 10.1016/j.yebeh.2021.108254

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Rzezak P, Valente KD, Duchowny MS. Temporal lobe epilepsy in children: executive and mnestic impairments. Epilepsy Behav. (2014) 31:117–22. doi: 10.1016/j.yebeh.2013.12.005

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Yang B, Wang X, Shen L, Ye X, Yang G-e, Fan J, et al. The attentional networks in benign epilepsy with centrotemporal spikes. Epilepsy Behav. (2015) 53:78–82. doi: 10.1016/j.yebeh.2015.09.034

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Kim SE, Lee JH, Chung HK, Lim SM, Lee HW. Alterations in white matter microstructures and cognitive dysfunctions in benign childhood epilepsy with centrotemporal spikes. Eur J Neurol. (2014) 21:708–17. doi: 10.1111/ene.12301

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Luo C, Zhang Y, Cao W, Huang Y, Yang F, Wang J, et al. Altered structural and functional feature of striato-cortical circuit in benign epilepsy with centrotemporal spikes. Int J Neural Syst. (2015) 25:1550027. doi: 10.1142/S0129065715500276

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Xiao F, Lei D, An D, Li L, Chen S, Chen F, et al. Functional brain connectome and sensorimotor networks in rolandic epilepsy. Epilepsy Res Jul. (2015) 113:113–25. doi: 10.1016/j.eplepsyres.2015.03.015

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Fritschy JM. Epilepsy, E/I Balance and GABA(A) Receptor Plasticity. Front Mol Neurosci. (2008) 1:5. doi: 10.3389/neuro.02.005.2008

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Badawy RA, Freestone DR, Lai A, Cook MJ. Epilepsy: Ever-changing states of cortical excitability. Neuroscience. (2012) 222:89–99. doi: 10.1016/j.neuroscience.2012.07.015

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Dai X-J, Xu Q, Hu J, Zhang Q, Xu Y, Zhang Z, et al. BECTS substate classification by granger causality density based support vector machine model. Front Neurol. (2019) 10:1201. doi: 10.3389/fneur.2019.01201

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Metz-Lutz MN, Filippini M. Neuropsychological findings in Rolandic epilepsy and Landau-Kleffner syndrome. Epilepsia. (2006) 47 Suppl 2:71–5. doi: 10.1111/j.1528-1167.2006.00695.x

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Rakhade SN, Jensen FE. Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol. (2009) 5:380–91. doi: 10.1038/nrneurol.2009.80

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Tsuboyama M, Lee Kaye H, Rotenberg A. Biomarkers obtained by transcranial magnetic stimulation of the motor cortex in Epilepsy. Front Integr Neurosci. (2019) 13:57. doi: 10.3389/fnint.2019.00057

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Manning JR, Jacobs J, Fried I, Kahana MJ. Broadband shifts in local field potential power spectra are correlated with single-neuron spiking in humans. J Neurosci. (2009) 29:13613–20. doi: 10.1523/JNEUROSCI.2041-09.2009

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Ray S, Maunsell JH. Different origins of gamma rhythm and high-gamma activity in macaque visual cortex. PLoS Biol. (2011) 9:e1000610. doi: 10.1371/journal.pbio.1000610

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Hill AT, Clark GM, Bigelow FJ, Lum JAG, Enticott PG. Periodic and aperiodic neural activity displays age-dependent changes across early-to-middle childhood. Dev Cogn Neurosci. (2022) 54:101076. doi: 10.1016/j.dcn.2022.101076

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Voytek B, Kramer MA, Case J, Lepage KQ, Tempesta ZR, Knight RT, et al. Age-related changes in 1/f Neural Electrophysiological Noise. J Neurosci. (2015) 35:13257–65. doi: 10.1523/JNEUROSCI.2332-14.2015

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Voytek B, Knight RT. Dynamic network communication as a unifying neural basis for cognition, development, aging, and disease. Biol Psychiatry. (2015) 77:1089–97. doi: 10.1016/j.biopsych.2015.04.016

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: self-limited epilepsy with centrotemporal spikes, repetitive transcranial magnetic stimulation, excitation-inhibition imbalance, spike-wave index, electrical status epilepticus in sleep

Citation: Yang Y, Han Y, Wang J, Zhou Y, Chen D, Wang M and Li T (2023) Effects of altered excitation–inhibition imbalance by repetitive transcranial magnetic stimulation for self-limited epilepsy with centrotemporal spikes. Front. Neurol. 14:1164082. doi: 10.3389/fneur.2023.1164082

Received: 12 February 2023; Accepted: 09 May 2023;
Published: 26 May 2023.

Edited by:

Peter Halasz, National Institute of Clinical Neurosciences, Hungary

Reviewed by:

Georgios Mikellides, University of Nicosia, Cyprus
Tao Yu, Beijing Institute of Functional Neurosurgery, China

Copyright © 2023 Yang, Han, Wang, Zhou, Chen, Wang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Tianfu Li, dGlhbmZ1bGkmI3gwMDA0MDtjY211LmVkdS5jbg==; Mengyang Wang, bWVuZ3lhbmd3YW5nJiN4MDAwNDA7Y2NtdS5lZHUuY24=

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.